Dr. Bryan Curtin is a Board Certified gastroenterologist with specialized expertise in gastrointestinal (GI) motility disorders.
Mercy doctors offer a breakthrough treatment for hepatitis C that cures most patients and saves lives. Hepatitis C is an infection of the liver caused by the hepatitis C virus and can lead to permanent liver damage if untreated.
The Vascular Center at Mercy provides vascular surgeons who treat conditions including aneurysm, stroke, swelling of the legs and vein blockages.
Mercy offers emergency care on the Downtown Baltimore campus 24 hours a day, 7 days a week (410-332-9477) with access to a trained emergency medicine team, diagnostic services and consultations with specialists.
In case of an Emergency, Dial 911 and follow the instructions of the EMS (Emergency Medical Services) team.
Mercy Medical Center's downtown campus includes our Main Hospital - The Mary Catherine Bunting Center, McAuley Plaza and The Weinberg Center.
General visiting hours at Mercy are 11:00 am to 8:30 pm. Hours vary by floor, please check with the nursing staff or call 410-332-9555.
Dr. Paul Thuluvath, Dr. Anurag Maheshwari and Dr. Hwan Yoo of The Center for Liver and Hepatobiliary Diseases at Mercy in Baltimore focus on finding the best treatment options available for non-alcoholic fatty liver disease. Dr. Thuluvath conducts non-alcoholic fatty liver disease research trials that provide recommendations and treatment options to reduce disease progression, review new modalities of treatment, and provide liver cancer screenings.
Non-alcoholic fatty liver disease, NAFLD, is a very common disease of the liver that affects people who do not drink much alcohol. When the liver has trouble breaking down fat, it builds up in the liver. This build-up of fat often does not cause any complications. However, in some cases, the fat build-up can cause:
Both these conditions of non-alcoholic fatty liver disease cause the liver to function improperly. Severe non-alcoholic fatty liver disease can lead to portal hypertension, liver cancer, or liver failure.
Risk factors of non-alcoholic fatty liver disease include obesity, hyperlipidemia (high triglycerides and high cholesterol), and type II diabetes. Appropriate and timely management may reduce the risk of non-alcoholic fatty liver disease.
Most people do not experience any symptoms of non-alcoholic fatty liver disease. If symptoms do occur, they can include:
Non-alcoholic fatty liver disease can be diagnosed using:
There are not specific treatment options for non-alcoholic fatty liver disease, though it is recommended that people with non-alcoholic fatty liver disease receive the hepatitis A vaccine and the hepatitis B vaccine. Most often, treatment involves reducing the non-alcoholic fatty liver disease risk factors. The more severe forms of non-alcoholic fatty liver disease, such as cirrhosis, require cancer screenings.
A patient tells of her experience participating in a clinical trial for NASH at Mercy in Baltimore.
The Institute for Digestive Health & Liver Disease at Mercy Medical Center brings Baltimore-based top gastroenterologists, doctors, surgeons and specialists to the patient communities of the Mid-Atlantic region with leading treatments for diseases and conditions affecting the digestive tract, including liver and hepatobiliary diseases, inflammatory bowel and colorectal diseases such as Crohn's disease or colitis, conditions of the pancreas, heartburn and reflux disease (GERD), and stomach and intestinal disorders.
Dr. Elinor Zhou is a gastroenterologist who provides care for general digestive disorders including colon
cancer screening and prevention, GERD, dyspepsia, altered bowel
habits and abdominal pain.
Learn more about a long-term health struggle and the trusting relationship one patient established with her doctor at The Institute for Digestive Health and Liver Disease.